Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants
Terminated
- Conditions
- Chronic Lung Disease of PrematurityBronchopulmonary DysplasiaRetinopathy of Prematurity (ROP)Intraventricular Hemorrhage
- Interventions
- Other: No Intervention
- First Posted Date
- 2020-08-10
- Last Posted Date
- 2023-03-24
- Lead Sponsor
- Oak Hill Bio Ltd
- Target Recruit Count
- 26
- Registration Number
- NCT04506619
- Locations
- 🇺🇸
Memorial Hospital of South Bend, South Bend, Indiana, United States
🇺🇸University of Mississippi Medical Center, Jackson, Mississippi, United States
🇺🇸Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
© Copyright 2025. All Rights Reserved by MedPath